CardioComm Solutions, Inc.: CardioComm Solutions Completes Issuance of Shares for Debt CardioComm Solutions, Inc. (TSXV: EKG) (
CardioComm or the
Company ), a global medical provider of consumer heart monitoring and medical electrocardiogram (
ECG ) software solutions, announced that it has completed its previously announced issuance of shares for debt (see the Company s press releases dated April 27, 2021 and April 8, 2021 for further details).
Under debt settlement agreements, the Company has issued an aggregate of 3,353,644 common shares of the Company (
Shares ) to directors, employees and consultants of the Company to settle debt for services provided to the Company. The Shares are subject to a four month hold period that expires September 12, 2021, in accordance with the policies of the TSX Venture Exchange and applicable securities laws.
CardioComm Solutions, Inc.: CardioComm Solutions to Issue Shares for Debt and Issue Stock Options
CardioComm Solutions, Inc. (TSXV: EKG) (
CardioComm or the
Company ), a global medical provider of consumer heart monitoring and medical electrocardiogram (
ECG ) software solutions, announced the proposed issuance of shares for debt and the issuance of stock options.
Under debt settlement agreements, the Company will issue an aggregate of 2,947,394 common shares of the Company (
Shares ) to a director, employees and consultants of the Company at a deemed price of $0.055 per Share. The Shares will be provided to settle debt for services provided to the Company and will be subject to a four month hold period in accordance with applicable securities laws.
CardioComm Solutions, Inc.: CardioComm Solutions to Issue Shares for Debt and Issue Stock Options
CardioComm or the
ECG ) software solutions, announced the proposed issuance of shares and the issuance of stock options.
Under shares for debt agreements, the Company will issue an aggregate of 406,250 common shares of the Company (
Shares ) to directors of the Company at a deemed price of $0.06 per Share. The Shares will be provided to settle debt for service expenses and will be subject to a four month hold period in accordance with applicable securities laws.
The Company also granted 62,500 stock options to a director of the Company, each option exercisable at $0.06 per Share for five years from the date of grant and vesting immediately. The options are subject to the provisions of the Company s Stock Option Plan, the policies of the TSX Venture Exchange and applicable securities laws.
CardioComm Solutions Lenders Take Shares To Settle Debt baltimorestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimorestar.com Daily Mail and Mail on Sunday newspapers.
CardioComm Solutions, Inc: CardioComm Solutions Lenders Take Shares To Settle Debt
TORONTO, ON / ACCESSWIRE / December 29, 2020 / CardioComm Solutions, Inc. (TSXV:EKG) (
CardioComm or the
Company ), a global medical provider of consumer heart monitoring and medical electrocardiogram (
ECG ) software solutions, announced that at the request of two of four lenders, CardioComm will be issuing common shares of the Company (each, a
Share ) to settle $250,000 worth of debt. Pursuant to debt settlement agreements with the two converting lenders, the Company will issue an aggregate of 5,000,000 Shares at a deemed price of $0.05 per Share to settle an aggregate of $250,000 of a total of $500,000 in debt owed by the Company to its secured lenders. The issuance of the Shares is subject to approval from the TSX Venture Exchange, and the Shares will be subject to a four month hold period in accordance with applicable securities laws.